When standard treatments like antibiotics cannot stop the immune system's overreaction, a patient's blood must be filtered to remove deadly toxins. That is where Efferon's devices, of absorbers of dangerous cytokines and toxins, step in to make a critical difference. Dima Romashin, Efferon's co-founder and CEO, compares what happens in the body during sepsis to a fire, where an immune response overwhelms the body rapidly. 'In a fire, there are two things: the flame itself and smoke that it produces,' he told TechCrunch. Although Efferon makes absorbers for adults, Efferon NEO, its pediatric device developed specifically for young kids, is proving especially effective. Since children have a significantly lower circulating blood volume, they require medical devices engineered specifically for their physiology, according to Romashin. Efferon NEO is used in intensive care units across 30 countries, including European hospitals, Saudi Arabia, and Thailand. The company is now preparing to...
learn more
